With more than 70 million people reportedly infected with the HIV virus, Scientists at the NIAID Laboratory of Viral Diseases have developed a novel treatment for HIV infection. The scientists developed nucleic acids that encode novel chimeric antigen receptor (CAR) proteins that can… Read More ›
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has launched a clinical trial of an investigational vaccine designed to protect against respiratory syncytial virus (RSV). The Phase 1 study will enroll… Read More ›
The National Institutes of Health has formed the Trans-NIH Pediatric Research Consortium to coordinate pediatric research programs across its institutes and centers. Nearly all of the 27 NIH institutes and centers fund some aspects of child health research. In fiscal… Read More ›
Women in early pregnancy who have high levels of a certain thyroid hormone may be at greater risk for gestational diabetes, compared to women who have normal levels of the hormone, according to researchers at the National Institutes of Health. Their… Read More ›
National Institute of Allergy and Infectious Diseases (NIAID) scientists are developing promising dengue virus vaccine candidates, with the goal of creating a vaccine that is protective against all four dengue virus serotypes. Preclinical and early phase clinical testing has been… Read More ›
Heavy rainfall in Kenya has left a trail of destruction in parts of the country, leading to deaths and rendering roads impassable. Some rivers have burst their banks and dams have overflown for the first time in many years.
An experimental vaccine regimen based on the structure of a vulnerable site on HIV elicited antibodies in mice, guinea pigs and monkeys that neutralize dozens of HIV strains from around the world.